DrugInserts.com: Trustworthy FDA Drug Information

Prescription Medications

Medications Updated During 2009, From Oldest to Newest

Page 1 of 419 1 2 3 4 5 » 10 15 20 25 30 Last Page »

Ethyol

Amifostine

By MedImmune, LLC | Last revised: 1 January 2009
Ethyol

ETHYOL (amifostine) is indicated to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer. ETHYOL is indicated to reduce the incidence of moderate to severe xerostomia in…

SINEMET CR (1)

CARBIDOPA AND LEVODOPA

By Bristol-Myers Squibb Pharma Company | Last revised: 1 January 2009
SINEMET CR (1)

SINEMET CR is indicated in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication…

TOBI

Tobramycin

By Novartis Pharmaceuticals Corporation | Last revised: 1 January 2009
TOBI

TOBI® is indicated for the management of cystic fibrosis patients with P. aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with FEV 1 <25% or >75% predicted, or patients colonized with…

CLONIDINE HYDROCHLORIDE (28)

CLONIDINE HYDROCHLORIDE

By Bryant Ranch Prepack | Last revised: 1 January 2009
CLONIDINE HYDROCHLORIDE (28)

Clonidine hydrochloride is indicated in the treatment of hypertension. Clonidine hydrochloride may be employed alone or concomitantly with other antihypertensive agents. CONTRAINDICATIONS: Clonidine hydrochloride tablets should not be used in…

Plavix (9)

Clopidogrel Bisulfate

By Bryant Ranch Prepack | Last revised: 1 January 2009
Plavix (9)

Plavix is a P2Y 12 platelet inhibitor indicated for: Acute coronary syndrome – For patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)] including patients who are to be managed medically…

Page 1 of 419 1 2 3 4 5 » 10 15 20 25 30 Last Page »